|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01875 TOT BIOPHARM-B
Nominal 
1.700 -0.100 (-5.556%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 2,785 | -12.531% | 3,184 | 3,583 | 0 | 0 |
| Property, plant, equip. & others | 695,804 | 49.530% | 465,328 | 307,668 | 290,367 | 300,230 |
| Land & other Lease Assets | 14,258 | -4.991% | 15,007 | 15,733 | 20,639 | 28,435 |
| Intangible Assets | 8,839 | 90.168% | 4,648 | 5,123 | 3,229 | 2,391 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 1,483 | 0 | 0 |
| Other Non-current Assets | 11,240 | -88.420% | 97,067 | 70,710 | 77,721 | 71,943 |
| 732,926 | 25.236% | 585,234 | 404,300 | 391,956 | 402,999 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 126,009 | 32.891% | 94,821 | 29,558 | 8,114 | 15,250 | |
| Trade Receivables | 85,789 | 74.638% | 49,124 | 11,735 | 1,536 | 6,741 | |
| Cash & Bank Balances | 351,600 | -15.839% | 417,769 | 152,805 | 225,533 | 539,180 | |
| Other Current Assets | 129,777 | 12.768% | 115,083 | 111,865 | 14,044 | 53,192 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 693,175 | 2.420% | 676,797 | 305,963 | 249,227 | 614,363 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 35,710 | 37.436% | 25,983 | 28,214 | 18,006 | 0 | ||
| S-T Debt & Leases | 42,772 | -44.489% | 77,051 | 147,654 | 1,323 | 62,775 | ||
| Other Current Liabilities | 304,004 | 76.425% | 172,313 | 84,940 | 33,414 | 84,011 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 382,486 | 38.911% | 275,347 | 260,808 | 52,743 | 146,786 | |||
| Net Current Assets | 310,689 | -22.608% | 401,450 | 45,155 | 196,484 | 467,577 | ||
| Total Assets Less Current Liabilities | 1,043,615 | 5.770% | 986,684 | 449,455 | 588,440 | 870,576 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 302,879 | 42.546% | 212,478 | 60,911 | 6,083 | 12,299 | |||
| Other Non-current Liabilities | 54,050 | -8.027% | 58,767 | 53,453 | 0 | 0 | |||
| 356,929 | 31.589% | 271,245 | 114,364 | 6,083 | 12,299 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 2,297,499 | 0.000% | 2,297,499 | 1,892,906 | 1,874,438 | 1,874,438 | ||||
| Reserves | (1,610,813) | 1.717% | (1,583,617) | (1,557,815) | (1,292,081) | (1,016,161) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 686,686 | -3.810% | 713,882 | 335,091 | 582,357 | 858,277 | ||||
| Non-controlling Interests | 0 | -- | 1,557 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 686,686 | -4.019% | 715,439 | 335,091 | 582,357 | 858,277 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 82,665 | -43.784% | 147,050 | 187,799 | 7,094 | 56,652 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 31,559,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.937 |